Filed: 11/9/2023ACC: 0000950123-23-009816
📋 What this filing means
OUP MANAGEMENT CO., LLC filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $44.47M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$44.47M
Total AUM (reported)
11.12M
Total Shares
Allocation by class
COMMON STOCK$25.46M57.3%
SPONSORED ADS$19.01M42.7%
Portfolio Concentration
Top 3$34.18M76.9%
4–10$10.09M22.7%
11–25$191.1K0.4%
Top 3 weight
76.9%
Top 10 weight
99.6%
Voting Authority Distribution
Total shares with voting rights: 11.12M
Sole
Full voting authority
11.12M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
Centessa Pharmaceuticals plc
SOLEShares2.94M
TypeSH
Market value$19.01M
42.74%
Sole
2.94M
Shared
0.00
None
0.00
Aerovate Therapeutics Inc.
SOLEShares603.76K
TypeSH
Market value$8.19M
18.43%
Sole
603.76K
Shared
0.00
None
0.00
Cyteir Therapeutics, Inc.
SOLEShares2.46M
TypeSH
Market value$6.99M
15.71%
Sole
2.46M
Shared
0.00
None
0.00
PMV Pharmaceuticals, Inc.
SOLEShares989.23K
TypeSH
Market value$6.07M
13.66%
Sole
989.23K
Shared
0.00
None
0.00
Graphite Bio
SOLEShares406.31K
TypeSH
Market value$1.01M
2.27%
Sole
406.31K
Shared
0.00
None
0.00
Selecta Biosciences, Inc.
SOLEShares862.54K
TypeSH
Market value$914.3K
2.06%
Sole
862.54K
Shared
0.00
None
0.00
Vor Biopharma Inc.
SOLEShares374.71K
TypeSH
Market value$794.4K
1.79%
Sole
374.71K
Shared
0.00
None
0.00
eFFECTOR Therapeutics, Inc.
SOLEShares1.03M
TypeSH
Market value$615.3K
1.38%
Sole
1.03M
Shared
0.00
None
0.00
Precision BioSciences, Inc.
SOLEShares1.12M
TypeSH
Market value$383.6K
0.86%
Sole
1.12M
Shared
0.00
None
0.00
Spero Therapeutics, Inc.
SOLEShares249.07K
TypeSH
Market value$301.4K
0.68%
Sole
249.07K
Shared
0.00
None
0.00
Ikena Oncology, Inc.
SOLEShares26.83K
TypeSH
Market value$116.2K
0.26%
Sole
26.83K
Shared
0.00
None
0.00
Homology Medicines, Inc.
SOLEShares64K
TypeSH
Market value$74.9K
0.17%
Sole
64K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Centessa Pharmaceuticals plcSOLE | Sponsored ADS | 2.94M | SH | $19.01M 42.74% | 2.94M | 0.00 | 0.00 |
Aerovate Therapeutics Inc.SOLE | Common Stock | 603.76K | SH | $8.19M 18.43% | 603.76K | 0.00 | 0.00 |
Cyteir Therapeutics, Inc.SOLE | Common Stock | 2.46M | SH | $6.99M 15.71% | 2.46M | 0.00 | 0.00 |
PMV Pharmaceuticals, Inc.SOLE | Common Stock | 989.23K | SH | $6.07M 13.66% | 989.23K | 0.00 | 0.00 |
Graphite BioSOLE | Common Stock | 406.31K | SH | $1.01M 2.27% | 406.31K | 0.00 | 0.00 |
Selecta Biosciences, Inc.SOLE | Common Stock | 862.54K | SH | $914.3K 2.06% | 862.54K | 0.00 | 0.00 |
Vor Biopharma Inc.SOLE | Common Stock | 374.71K | SH | $794.4K 1.79% | 374.71K | 0.00 | 0.00 |
eFFECTOR Therapeutics, Inc.SOLE | Common Stock | 1.03M | SH | $615.3K 1.38% | 1.03M | 0.00 | 0.00 |
Precision BioSciences, Inc.SOLE | Common Stock | 1.12M | SH | $383.6K 0.86% | 1.12M | 0.00 | 0.00 |
Spero Therapeutics, Inc.SOLE | Common Stock | 249.07K | SH | $301.4K 0.68% | 249.07K | 0.00 | 0.00 |
Ikena Oncology, Inc.SOLE | Common Stock | 26.83K | SH | $116.2K 0.26% | 26.83K | 0.00 | 0.00 |
Homology Medicines, Inc.SOLE | Common Stock | 64K | SH | $74.9K 0.17% | 64K | 0.00 | 0.00 |